tag:blogger.com,1999:blog-8550428.post6468480050900280043..comments2024-03-28T13:38:36.788-04:00Comments on Pharma Marketing Blog: Shire Implements First Ever Integrated Phone-Assisted Social Network Marketing Campaign for ADHD!Vladhttp://www.blogger.com/profile/04114063498108633047noreply@blogger.comBlogger9125tag:blogger.com,1999:blog-8550428.post-9502722400205220692010-07-21T16:40:28.704-04:002010-07-21T16:40:28.704-04:00Hi John,
Ran across this post today and found it i...Hi John,<br />Ran across this post today and found it interesting! Thanks for sharing the call. Did you ever have the Shire representative on your Blog radio show? I'd love to hear an update on how they're handling DM requests through their call center. Today, the Twitter account has nearly 2,000 followers but they are still not following. Thanks!<br />--Nicole Johnson @nicoleljohnsonNicole Johnsonhttp://www.twitter.com/nicoleljohnsonnoreply@blogger.comtag:blogger.com,1999:blog-8550428.post-18371637041395515322010-01-08T14:55:21.080-05:002010-01-08T14:55:21.080-05:00Well then...how come every other pharma twitter ac...Well then...how come every other pharma twitter account follows people back? What's so special about this effort that changes that?Jonathan Richmanhttp://www.doseofdigital.comnoreply@blogger.comtag:blogger.com,1999:blog-8550428.post-63621038920873420132009-12-30T11:35:50.423-05:002009-12-30T11:35:50.423-05:00Um: "who cares!?"
Kudos to the agency w...Um: "who cares!?"<br /><br />Kudos to the agency which talked their client (Shire) into spending a quarter million bucks on this (when you add up time, planning, approval, etc., it can't be far from that). I don't see how this can help anyone except the people who cashed Shire's checks.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-8550428.post-26598932245137884652009-12-23T14:42:06.884-05:002009-12-23T14:42:06.884-05:00Couldn't resist, that is ;-)Couldn't resist, that is ;-)PharmaGuyhttps://www.blogger.com/profile/10211557578124130640noreply@blogger.comtag:blogger.com,1999:blog-8550428.post-7960401660992357462009-12-23T14:41:25.611-05:002009-12-23T14:41:25.611-05:00Jeff,
You are quite right about this being a phar...Jeff,<br /><br />You are quite right about this being a pharma industry issue and not just limited to Shire. I did think it was funny to refer to a 1-800 for submitting comments and I just could resist seeing if the person who answered knew anything at all about this.<br /><br />I did get a call back from a Shire corporate communication person and I hope to have him as a guest on my BlogTalkRadio show to give his side of the story.PharmaGuyhttps://www.blogger.com/profile/10211557578124130640noreply@blogger.comtag:blogger.com,1999:blog-8550428.post-47144041680650093672009-12-23T14:35:21.297-05:002009-12-23T14:35:21.297-05:00John, thanks for blogging about this feed, I hadn&...John, thanks for blogging about this feed, I hadn't seen it previously. But is that sarcasm I hear? I'm pretty sure you know why manufacturers don't feel comfortable following people on Twitter ... point taken but you could make the post stronger by acknowledging this isn't a Shire-specific issue, but an industry one.<br /><br />PS to anonymous - John Mack is one of the few must-reads in pharma .. if only because the guy's everywhere (Twitter, blog, email, widgets, BlogTalkRadio, FDA hearings ... !)<br /><br />Jeff Greene<br />HealthEd GroupJeff Greenehttp://www.twitter.com/healtheddigitalnoreply@blogger.comtag:blogger.com,1999:blog-8550428.post-41633825960540407282009-12-23T07:16:30.030-05:002009-12-23T07:16:30.030-05:00It was LAURA LANDRO in the article "What the ...It was LAURA LANDRO in the article "What the In-Crowd Knows" published in the November 16, 2005 issue (find the article here: http://bit.ly/7IByPo). Subtitle: "From Hollywood to Wall Street, Our Guide to the Blogs Insiders Read to Stay Current"<br /><br />In the intro, Landro says: "No self-respecting industry these days is without a must-read blog." Since PMB is on her list, it is appropriate to use the "must read" quote.<br /><br />Here's her complete review of PMB:<br /><br />"The site focuses on how drug companies can get accurate and trustworthy information to doctors and consumers. John Mack, publisher of the monthly online newsletter Pharma Marketing News, started his blog in January 2005. He offers commentary on news events and is often critical of the industry's focus on blockbuster drugs and what Mr. Mack views as unethical or misguided marketing. Among his pet peeves is erectile-dysfunction advertising, which he believes focuses too heavily on younger men and libido-enhancing promises while failing to educate consumers about the disease. The site lambastes pharma companies for ads that foster a "magic pill solution preference among Americans," while rarely mentioning changes in lifestyle or diet that will help reduce risks such as cardiovascular disease. But he's quick to praise efforts that address the industry's credibility problem with consumers, such as Johnson & Johnson's new TV and print campaigns that he says put drug risks on more-equal footing with drug benefits."PharmaGuyhttps://www.blogger.com/profile/10211557578124130640noreply@blogger.comtag:blogger.com,1999:blog-8550428.post-55986330378729872712009-12-22T18:47:31.014-05:002009-12-22T18:47:31.014-05:00Not a bad start but of the 190 followers more than...Not a bad start but of the 190 followers more than 70% are in the industry.Richard Meyerhttp://www.worldofdtcmarketing.comnoreply@blogger.comtag:blogger.com,1999:blog-8550428.post-77745566246094605272009-12-22T18:38:44.288-05:002009-12-22T18:38:44.288-05:00Who exactly from the Wall Street Journal said this...Who exactly from the Wall Street Journal said this was a "must read" blog for insiders? Just curious since the name is absent.Anonymousnoreply@blogger.com